Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry

BACKGROUND: Real‐world data describing outcomes of treatment among metastatic renal cell carcinoma (mRCC) patients are limited and heterogeneous. AIM: RENSUR3 registry study assessed real‐world data on the use of therapies in mRCC and overall survival (OS) in Russia, Kazakhstan, and Belarus. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsimafeyeu, Ilya, Shatkovskaya, Oxana, Krasny, Sergei, Nurgaliev, Nurzhan, Varlamov, Ilya, Petkau, Vladislav, Safina, Sufia, Zukov, Ruslan, Mazhbich, Mikhail, Statsenko, Galina, Varlamov, Sergey, Novikova, Olga, Zaitsev, Igor, Moiseyev, Pavel, Rolevich, Alexander, Evmenenko, Alesya, Popova, Irina, Kaidarova, Dilyara, Vladimirova, Liubov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222559/
https://www.ncbi.nlm.nih.gov/pubmed/33369240
http://dx.doi.org/10.1002/cnr2.1331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222559/
https://www.ncbi.nlm.nih.gov/pubmed/33369240
http://dx.doi.org/10.1002/cnr2.1331

Ejemplares similares